FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy ...Middle East

STOCKHOLM, Aug. 18, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT), (Nasdaq Stockholm: CALTX) ("Calliditas"), today announced that the U.S. Food and Drug Administration (FDA) has accepted the submission for the supplemental New Drug Application (sNDA) for TARPEYO®...

Hence then, the article about fda grants priority review for full approval of tarpeyo for the treatment of iga nephropathy was published today ( Friday 18/08/2023 - 11:25 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy )

Also on site :

• Help! My Friend Volunteered to Dog-Sit for Months. I’m Horrified by What I Caught Him Doing on My Secret Camera.
• ’80s Thrash Metal Frontman, Who Survived Rare Cancer, Announces New Project
• Zelensky’s favorite drone company at center of Ukrainian corruption alert